Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.

Powers Health Forges Prime Vendor Agreement With Medline

Medline announced it has entered into a new multi-year Prime Vendor agreement with Powers Health, a non-profit health system, to distribute medical-surgical supplies, including sterile procedure trays, across its multiple points of care, including acute care, environmental services, lab and physician offices.

Saluda Medical Appoints Barry Regan as Chief Executive Officer

Saluda Medical, a pioneer in the development and commercialization of a novel neuromodulation platform designed to transform the lives of patients with chronic neurological conditions, announced the appointment of Barry Regan as President and Chief Executive Officer effective as of July 14, 2025. In his most recent roles, Mr. Regan served as Executive Vice President, Global Operations at Dexcom and Senior Vice President, Global Operations at Wright Medical.

Halozyme Therapeutics Added to Russell 1000 Index

Halozyme Therapeutics, announced that it has been added to the U.S. large-cap Russell 1000 Index, effective after market close on June 27th, as part of the 2025 FTSE Russell indexes annual reconstitution.

The Russell 1000 Index includes approximately 1,000 of the largest U.S. securities based on market capitalization and is widely used by investors as a benchmark for the performance of large-cap stocks.

Mindspire Launches Pre-Orders for Sona, AI-Powered Calm Wearable

Forget deep breaths and doom scrolling, your nervous system’s new BFF is here. Meet SONA, a discreet ear-worn device that uses adaptive AI and vagus nerve stimulation to deliver instant, personalised stress relief whenever you need it most.

Jade Biosciences Appoints Brad Dahms as Chief Financial Officer

Jade Biosciences, a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, announced the appointment of Brad Dahms as Chief Financial Officer.

To share your insights, please write to us at sudipto@intentamplify.com